Comparison of blood RNA extraction methods used for gene expression profiling in amyotrophic lateral sclerosis.
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that causes death within a mean of 2-3 years from symptom onset. There is no diagnostic test and the delay from symptom onset to diagnosis averages 12 months. The identification of prognostic and diagnostic biomarkers in ALS would fa...
Saved in:
| Main Authors: | Nadhim Bayatti, Johnathan Cooper-Knock, Joanna J Bury, Matthew Wyles, Paul R Heath, Janine Kirby, Pamela J Shaw |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2014-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0087508&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
C9ORF72 GGGGCC Expanded Repeats Produce Splicing Dysregulation which Correlates with Disease Severity in Amyotrophic Lateral Sclerosis.
by: Johnathan Cooper-Knock, et al.
Published: (2015-01-01) -
Mutations in CHMP2B in lower motor neuron predominant amyotrophic lateral sclerosis (ALS).
by: Laura E Cox, et al.
Published: (2010-03-01) -
Evaluation of a biomarker for amyotrophic lateral sclerosis derived from a hypomethylated DNA signature of human motor neurons
by: Calum Harvey, et al.
Published: (2025-01-01) -
Blood diagnostic and prognostic biomarkers in amyotrophic lateral sclerosis
by: Yongting Lv, et al.
Published: (2025-09-01) -
Management of Dysarthria in Amyotrophic Lateral Sclerosis
by: Elena Pasqualucci, et al.
Published: (2025-07-01)